Skip to main content
Clinical Trials/NCT04506385
NCT04506385
Completed
Not Applicable

Effects of Probiotics Administration on Human Metabolic Phenotype

Probiotical S.p.A.1 site in 1 country42 target enrollmentApril 20, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metabolomic Profile
Sponsor
Probiotical S.p.A.
Enrollment
42
Locations
1
Primary Endpoint
metabolomic profile
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Background: The establishment of the beneficial interactions between the host and its microbiota is essential for the development and correct functioning of the organism, since microflora alterations can lead to many chronic degenerative diseases. In this context, probiotics are used to improve balanced microbial communities and therefore exert substantial health-promoting effects to the host.

Objective: The aim of the present study is to monitor the molecular outcomes, obtained by gut microflora modulation through probiotic treatment, on human urine and serum metabolic profiles, with a 1H-Nuclear Magnetic Resonance -based metabolomic approach.

Detailed Description

Design: In a first phase twenty-two healthy subjects are enrolled in the study and administered with Lactobacillus delbrueckii subs. delbrueckii and/or a mix of 5 biotypes of Bifidobacterium longum for 8 weeks. In the second phase subjects are enrolled in the study and administered with Lactobacillus rhamnosus, Lactobacillus plantarum, Lactobacillus fermentum and Bifidobacterium longum at two different concentration. During the course of the study all the probiotic types were administered both singularly and in combination. From each subject urine and serum samples are collected before and during the supplementation and are analysed by nuclear magnetic resonance spectroscopy and statistical analyses.

Registry
clinicaltrials.gov
Start Date
April 20, 2020
End Date
March 31, 2021
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Probiotical S.p.A.
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • healthy subjects

Exclusion Criteria

  • previous surgery on the intestinal tract;
  • a probiotic / prebiotic and antibiotic treatments within 3 and 1 months, respectively, before the beginning of the study;
  • subjects have changed drastically their diet or lifestyle during the study.

Outcomes

Primary Outcomes

metabolomic profile

Time Frame: 20 days

To monitor the molecular outcomes, obtained by gut microflora modulation through probiotic treatment, on human urine and serum metabolic profiles, with a 1H-Nuclear Magnetic Resonance-based metabolomic approach

Study Sites (1)

Loading locations...

Similar Trials